Abstract
Sorafenib (SFN) is an anticancer multi-kinase inhibitor with great therapeutic potential. However, SFN has low aqueous solubility, which limits its or......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
